誉衡药业

- 002437

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
誉衡药业(002437) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入122,131.0659,313.33262,603.93205,200.85143,266.32
营业收入122,131.0659,313.33262,603.93205,200.85143,266.32
二、营业总成本110,827.9455,336.43248,929.39193,703.67133,998.87
营业成本56,141.4627,397.34109,271.1143,869.9430,068.00
营业税金及附加1,707.62705.633,611.872,825.941,982.67
销售费用42,815.9721,936.89106,851.87126,734.6288,243.45
管理费用7,236.773,693.5917,519.4911,573.217,786.68
财务费用115.69132.503,131.242,666.522,238.93
研发费用2,810.421,470.498,543.826,033.443,679.15
资产减值损失----------
公允价值变动收益-1,087.63-1,140.57-1,793.43-1,658.67-1,367.05
投资收益602.8068.72-2,343.809,318.71-4,419.29
其中:对联营企业和合营企业的投资收益52.5668.72-2,475.559,196.14-4,539.72
汇兑收益----------
三、营业利润15,326.616,844.9117,504.6626,040.975,137.14
加:营业外收入7.152.97266.0860.3037.75
减:营业外支出26.836.5292.9381.4836.81
其中:非流动资产处置损失----------
四、利润总额15,306.926,841.3617,677.8126,019.795,138.08
减:所得税费用2,154.351,265.254,807.752,913.681,909.78
五、净利润13,152.585,576.1012,870.0623,106.113,228.30
归属于母公司所有者的净利润12,497.085,228.2912,033.4222,362.352,824.90
少数股东损益655.50347.81836.65743.75403.40
六、每股收益
基本每股收益(元/股)0.05560.02350.05470.10170.0129
稀释每股收益(元/股)0.05560.02350.05470.10170.0129
七、其他综合收益22.547.1385.51136.14164.02
八、综合收益总额13,175.125,583.2412,955.5723,242.253,392.33
归属于母公司所有者的综合收益总额12,519.625,235.4212,118.9322,498.502,988.93
归属于少数股东的综合收益总额655.50347.81836.65743.75403.40
下载全部历史数据到excel中 返回页顶